Growth and growth hormone therapy in children with achondroplasia: a two-year experience.

@article{Stamoyannou1997GrowthAG,
  title={Growth and growth hormone therapy in children with achondroplasia: a two-year experience.},
  author={Lela Stamoyannou and Feneli Karachaliou and Polyxeni Neou and K Papataxiarchou and G Pistevos and Christos S. Bartsocas},
  journal={American journal of medical genetics},
  year={1997},
  volume={72 1},
  pages={71-6}
}
The efficacy and safety of recombinant human growth hormone (hGH) administration was studied in children with achondroplasia. Fifteen children with achondroplasia, seven boys (4.8-12.2 years of age) and 12 girls (5.7-2.2 years of age), were treated daily with hGH at a dosage of 1 IU/kg/week. Auxological assessments were performed 6 months before, at initiation of, and at 6, 12, and 24 months following initiation of growth hormone (GH) therapy. Before initiating GH therapy, hypothalamic… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…